Ozempic Weight Loss Drug Litigation Signed Cases
Claims against Ozempic declare that the drug can cause major gastrointestinal concerns, including gastroparesis, ileus, and digestive tract blockage. Plaintiffs assert that the drug’s suppliers were negligent in not alerting individuals of these possible side effects. The very first legal action was submitted on August 2, 2023, and as of November 2023, there were no class action fits or Multidistrict Lawsuits (MDL) cases related to Ozempic.
Ozempic is a brand name for semaglutide and is made by Novo Nordisk. Bjorklund’s legal action consisted of the medication Mounjaro (tirzepatide) and named Eli Lilly, its producer, as a defendant.
Why Are People Submitting Ozempic Lawsuits?
The current Ozempic claims were started by individuals who experienced gastroparesis after utilizing the drug. Gastroparesis is a major condition where food passes through the stomach to the small intestine at an unusually slow-moving rate. In specific circumstances, the activity of food via the intestine might totally halt.
Gastroparesis can cause a variety of undesirable signs, including nausea, vomiting, bloating, and stomach pain. It can likewise create severe dehydration, indigestion, lack of nutrition, and weight loss. In some cases, undigested food might stay in the stomach and harden, creating discomfort and more difficulties.
The FDA issued a caution for Ozempic in September 2023 pertaining to the risks of digestive tract obstruction, intestinal blockage, and ileus. Ileus is a medical problem that interrupts the regular functioning of the intestines. Legal professionals are currently approving instances associated with these issues.
Ozempic is a member of a drug course called GLP-1 agonists, which are currently under investigation by lawyers for feasible connections to gastroparesis, ileus, and digestive blockage. Various other medicines in this course that are being taken looked at for similar cases consist of:
Mounjaro, Rybelsus, Saxenda, and Wegovy are the names of various medications.
According to Ozempic lawsuits, considering that the FDA accepted Ozempic in 2017, Novo Nordisk has not included gastroparesis warnings in its prescription info. The company alerted regarding various other Ozempic adverse effects yet really did not warn the general public of the risk of extreme gastroparesis.
People impacted by gastroparesis are looking for repair for a decreased quality of life, as well as settlement for past and future clinical costs, and other associated problems, as there is no well-known remedy for this problem.
In the most recent Ozempic lawsuits, the key injury being affirmed is gastroparesis, which refers to a stomach that is paralyzed. This condition brings about intense vomiting that can persist for a period of 4 weeks or longer. Gastroparesis can also be connected to gastroenteritis, which is inflammation of the stomach. Besides gastroparesis, legal professionals are analyzing instances of ileus, which is a clog or blockage in the intestinal tracts.
Who Qualifies to File an Ozempic Legal Action?
People who have actually taken Ozempic for fat burning or other functions may be eligible to submit a claim if they have actually experienced gastroparesis, ileus, intestinal blockage, and/or intestinal obstruction.
At present, Ozempic might not be a choice for people who have gone through stomach bypass, stomach banding, or stomach sleeve surgical procedures. In addition, lawyers are not accepting instances involving Ozempic if the individual is all at once obtaining cancer treatment.
How We Can Help Your Ozempic Litigation Practice Grow
We focus our advertising efforts on TV, radio, organic SEO (Google, Bing, Yahoo), Google Maps, Google Ads, Bing, Facebook, and Instagram, but depending on your ideal client profile, we may turn to other platforms. Unlike other mass tort ad agencies, we have experience with a number of different ad platforms, so we can use just the right one to get the job done. Our focus is on mobile marketing, utilizing Voice Search, to capture some of the best and highest-converting leads.
We also use remarketing and behavioral targeting in our lead-generation campaigns. Remarketing and behavioral targeting allow us to target the right people at the right time with the right message to get them on the phone.
Our latest technology utilizes our proprietary software that enables us to data mine information through third-party vendors, resulting in cases where leads have been matched with their medical histories, diagnosis, drug prescription, and treatments with exposure or usage of a caustic drug or chemical. This significantly reduces the cost of acquisition and provides a much higher value clients; one that has proof of usage or exposure; proof of diagnosis; and proof of treatment.
Get started before your competitors do. There are only so many clients we can serve.
CONTACT US FOR A CUSTOM QUOTE.
CALL 833-937-6747 OR USE OUR REQUEST A QUOTE FORM.